Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68 | 91 | 151 | 428 | 515 |
| Receivables | 15 | 8 | 12 | 7 | 12 |
| Inventories | 41 | 52 | 54 | 52 | 55 |
| TOTAL | $127 | $152 | $217 | $487 | $582 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 1 |
| Other Non-Current Assets | 47 | 49 | 52 | 55 | 55 |
| TOTAL | $47 | $49 | $52 | $55 | $56 |
| Total Assets | $174 | $201 | $269 | $543 | $638 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 648 | 473 | 339 | 971 | 975 |
| Other current liabilities | N/A | 100 | 100 | 100 | 100 |
| TOTAL | $748 | $682 | $558 | $1,594 | $1,576 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 9 | 19 | 22 | 24 |
| Other Non-Current Liabilities | 211 | 0 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $748 | $682 | $558 | $1,594 | $1,576 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,154 | 72,356 | 72,081 | 66,586 | 65,067 |
| Common Shares | 49 | 48 | 47 | 45 | 44 |
| Retained earnings | -73,983 | -73,445 | -72,799 | -71,078 | -70,163 |
| Other shareholders' equity | -100 | 36 | 0 | 0 | 0 |
| TOTAL | $-575 | $-481 | $-290 | $-1,051 | $-938 |
| Total Liabilities And Equity | $174 | $201 | $269 | $543 | $638 |